Predict your next investment

SpIntellx company logo

See what CB Insights has to offer

Founded Year



Seed | Alive

Total Raised


About SpIntellx

SpIntellx is a computational pathology company that develops AI tools based on spatial analytics. SpIntellx aims to develop tools that improve the accuracy and efficiency of pathologists and to generate predictive data to optimize patient outcomes. The company's product, HistoMapr, is a computational guide for pathologists that automatically recognizes and classifies regions of interest in H&E-stained and immunohistochemistry slides.

SpIntellx Headquarter Location

2425 Sidney Street

Pittsburgh, Pennsylvania, 15203,

United States

Latest SpIntellx News

Meet the 7 life science startups of AlphaLab Health’s inaugural accelerator cohort

Jun 14, 2021

This biotechnology company develops pharmaceutical treatment for cytokine release syndrome (CRS) — sometimes referred to as the “cytokine storm” — which is the result of an overactive immune system response that can lead to serious inflammation. CytoAgents’ current lead drug candidate is GP1681, a pharmaceutical that can interrupt the cytokine amplification pathway, preventing an immune system overreaction. So far, the company has completed Phase I clinical trials for GP1681 with positive results, and the Pittsburgh-based team led by CEO Teresa Whalen is now seeking a $25 million Series A funding round for Phase II trials, which will examine the efficacy of their drug against CRS symptoms induced by CAR-T cell therapy and COVID-19. Emergence Dental improves bone grafting procedures with a medical device that uses metallic magnesium alloys to support bone regeneration while also safely resorbing into the body over a six-month time period. The company’s lead product seeks to resolve bone grafting’s relatively low success rate , and to reduce the cost and unpredictability of the procedure for oral surgeons and periodontists. Pittsburgh’s Emergence Dental, led by CEO Andrew Brown, is now starting preclinical testing of its resorbable magnesium product for dental bone grafting. Sarah Palya, CEO and founder of Valencia-based Gus Gear, initially developed her company’s line of products as a response to the challenges she faced in protecting her son’s central line, aka central venous catheter. Gus Gear’s flagship product, the Central Line Vest, secures a patient’s central line or catheter within a flexible vest to protect it from any accidental disruption or line breaks. The company also offers G-tube wraps, ostomy pouch covers, and line covers for similar protection. With its products already used in 55 children’s hospitals, Gus Gear is now enrolling for a clinical trial to obtain a reimbursement code  for the Central Line Vest, and is currently raising a seed round to support further business growth. JuneBrain’s technology centers on a remote retinal imaging system that can help patients detect changes in their eye or brain health from home. Leveraging telemedicine practices that have become more popular during the pandemic, JuneBrain’s virtual reality mask device can detect and monitor diseases linked to retinal changes by performing a version of the optical coherence tomography test. Data collected from the device is then automatically shared with physicians, allowing them to regularly track retinal health and quickly diagnose diseases like multiple sclerosis or macular degeneration. The four-year-old company founded by Samantha Scott is based in Rockville, Maryland. Using computer vision and machine learning, Sterile Vision tracks the use of surgical tools in the operating room to help identify places to reduce cost and streamline the tool sterilization and preparation processes. By monitoring tool use, Sterile Vision’s platform can pinpoint those that are rarely or never used by surgeons, and help eliminate unnecessary ones to help increase efficiency in the operating room and lower the cost of sterilization. The Pittsburgh-based company was cofounded by Dr. Duken LaBaze and Dr. Stephen P. Canton. It’s currently working on market fit testing within the Allegheny Health Network. As an improved mode of therapy for obstructive sleep apnea, sovaSage developed a product that leverages machine learning, computer vision and smartphones to improve CPAP mask fit. By creating a digital profile of a patient’s anatomical characteristics, behavioral sleep patterns and other relevant health information, sovaSage helps provide sleep apnea therapists with easy access to detailed patient information. The Pittsburgh company, cofounded by William Kaigler and Christian Kebekus, also developed face-modeling technology that allows users to take a selfie that can then be scanned to assess appropriate mask fit. With their main product already used by durable medical equipment providers across the United States and Canada, sovaSage will further diversify their product line in the future. Pittsburgh’s SpIntellx, cofounded by S.  Chakra Chennubhotla and D. Lansing Taylor, uses spatial intelligence to better understand cell and tissue relationships in a way that improves pathology, or understanding the cause of a given disease, in precision medicine. In addition to the data collected through this platform, SpIntellx also employs explainable artificial intelligence (xAI) to help physicians and technicians understand the conclusions made by algorithms, so that medical professionals still remain in control of final decisions. So far, the company has two product platforms — TumorMapr and HistoMapr — that apply their proprietary technology to examining tumor progression and histological patterns, respectively.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing SpIntellx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SpIntellx is included in 6 Expert Collections, including Artificial Intelligence ( AI ) in Healthcare.


Artificial Intelligence ( AI ) in Healthcare

826 items

These healthcare startups are using AI to discover new drugs, remotely monitor patients, securely transfer patient data, and more.


Artificial Intelligence

7,394 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Medical Devices

7,867 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



5,880 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Digital Health

11,220 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.


Health Monitoring & Diagnostics

311 items

Companies developing technology for computer-aided diagnostic imaging. Companies tagged as #ComputerAidedDxImaging

SpIntellx Patents

SpIntellx has filed 1 patent.

The 3 most popular patent topics include:

  • Computer science conferences
  • Image processing
  • Magnetic resonance imaging
patents chart

Application Date

Grant Date


Related Topics



SAGE sites, Microscopy, Image processing, Computer science conferences, Magnetic resonance imaging


Application Date


Grant Date


Related Topics

SAGE sites, Microscopy, Image processing, Computer science conferences, Magnetic resonance imaging



CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.